Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 28-Jun-2022 titled Glenmark Pharmaceuticals Inc., USA continues to expand its Over���The���Counter (OTC) Portfolio with the acquisition of approved ANDAs from Wockhardt Limited